Epitalon
Epithalon · AEDG
Epitalon and Epithalon are alternative names used for the AEDG tetrapeptide. This reference keeps one entry for both spellings and separates cell-culture telomere findings from longevity claims.
Reviewed September 2026
- Residues
- 4. calculated: Count of residues in the stored canonical reference sequence; terminal groups are not extra residues.
- Average mass
- 390.35 Da. calculated: Calculated average neutral molecular mass of the unmodified free-terminal sequence, including one terminal water. Not monoisotopic mass; salts, counterions and solvates excluded.
- pI
- 3.67 (theoretical). calculated: Theoretical Bjellqvist/Biopython charge-model pI for the stated free-terminal, unmodified sequence (pH search 0–14). Model-dependent, not measured pI or formulation pH; not applicable to an unspecified amidated, acetylated or salt preparation.
Primary structure
Sequence
Peptide. Sequence describes the reference peptide, not a tested supplier lot.
Calculated properties
| Formula | C14H22N4O9 |
|---|---|
| Monoisotopic mass | 390.1387 Da |
| Extinction coefficient at 280 nm | None (no Tyr or Trp) |
| A280 at 1 mg/mL | Not measurable |
| Residues | 4 |
| Average mass | 390.35 Da |
| pI | 3.67 (theoretical) |
| Aliases | Epithalon, AEDG |
|---|---|
| Sequence | AEDG |
| Research area | Cellular and longevity |
Property basis and sources
These describe the reference compound or formulation, not identification or testing of the supplied lot.
Calculation scope: the stored canonical amino-acid sequence with free N- and C-termini, no other modifications or counterions. This specifies a reference form, not the chemical form or identity of a sold lot.
- Residues: 4 (calculated). Count of residues in the stored canonical reference sequence; terminal groups are not extra residues. Residues source 1
- Average mass: 390.35 Da (calculated). Calculated average neutral molecular mass of the unmodified free-terminal sequence, including one terminal water. Not monoisotopic mass; salts, counterions and solvates excluded. Average mass source 1 Average mass source 2 Average mass source 3
- pI: 3.67 (theoretical) (calculated). Theoretical Bjellqvist/Biopython charge-model pI for the stated free-terminal, unmodified sequence (pH search 0–14). Model-dependent, not measured pI or formulation pH; not applicable to an unspecified amidated, acetylated or salt preparation. pI source 1 pI source 2
Residue composition
- Unique residues
- 4
- Most common
- Alanine
- Nonpolar residues
- 0
- Other classified residues
- 4
Alanine is the most common residue (1). The calculated charge at pH 7 is net negative (-2.01).
Reference scope and linked records
Reference type: Peptide.
This is a research-reference entry, not a product certificate, treatment recommendation or administration guide. The sources below describe their own materials and methods. Catalogue identity, lot testing and clinical evidence are separate questions.
Catalogue context: Epithalon. The product retains its own name and specification; this link does not certify equivalence to published study material.
Related references
Sources and their scope
- Epithalon induces telomerase activity and telomere elongation in human somatic cells. Source for the chemistry or study context discussed above; not an Aminos lot certificate.
- Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. Source for the chemistry or study context discussed above; not an Aminos lot certificate.
Source check: 26 September 2026. This is an editorial source check, not a claim of independent clinical or laboratory review.
About Epitalon
Identity and context
The compound should not be confused with a heterogeneous pineal extract or with an unspecified anti-ageing blend. A short peptide identity is a chemical description, not evidence that the molecule slows ageing in people.
Reference classification
Peptide. The linked catalogue product is Epithalon. This reference does not independently authenticate the material supplied.
Storage and handling
Analytical specification
Keep the AEDG sequence and terminal chemistry on the specification. Do not substitute studies of an extract, or assume that identical marketing language identifies identical material.
Storage and experimental handling
Use the documented conditions for the actual chemical form and preparation. No universal storage temperature, expiry or solution shelf life is assigned here. Follow the lot documentation, safety data sheet and validated laboratory protocol; this page is not a reconstitution or administration guide.
Research evidence
| Area | Summary | Evidence |
|---|---|---|
| What the source examines | The 2003 paper reported telomerase activity and telomere elongation in human fetal fibroblast culture. A 2025 study examined normal and cancer cell lines, reporting different pathways associated with telomere extension, including alternative lengthening of telomeres in cancer cells. | Source context |
| What cannot be inferred | Telomere length is a laboratory endpoint, not a demonstrated increase in healthy human lifespan. Responses in cancer cells also make a simple narrative of universal benefit inappropriate. Neither paper tests the current Aminos lot. | Evidence limits |
References
Sources used for the data on this page, checked September 2026.
- Epithalon induces telomerase activity and telomere elongation in human somatic cellsPrimary source for the reference discussion; not lot-specific product evidence.
- Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activityPrimary source for the reference discussion; not lot-specific product evidence.
Reference information only. This page describes the chemistry and published research context of a laboratory compound. Nothing here is medical or dosing advice. Aminos compounds are for laboratory research use only and are not medicines.